n a landmark development for global cancer care, Cipla Limited (BSE: 500087; NSE: CIPLA EQ), a leading global pharmaceutical company, today announced that it has received final approval from the United States Food and Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for
Granules India Limited (BSE: 532482, NSE: GRANULES) today announced the successful closing of the acquisition of Senn Chemicals AG, a Swiss- based Contract Development and Manufacturing Organization (CDMO) specializing in peptide development and manufacturing. This marks a strategic milestone in Granules’ transformation into a science-
In a significant policy development, the Government of Gujarat has reversed its earlier decision to exempt stents from the purview of central pricing regulation under the Clinical Establishments Act. This comes after broad-based feedback and concern from industry stakeholders, patient advocacy groups, and healthcare experts. Simultaneously,
As part of its Corporate Social Responsibility (CSR) initiative, Granules India Limited, a leading pharmaceutical company based in Hyderabad in collaboration with AIG Hospitals, successfully conducted a Breast Health Screening and Awareness Camp for women police officials at the Telangana State Police Headquarters. This initiative
Mankind Pharma, India's fourth-largest pharmaceutical company, has announced the launch of its new campaign for HealthOK 100% vegetarian multivitamin tablets, featuring popular actress Archana Puran Singh, a strict vegetarian herself. This campaign aims to raise awareness about HealthOK's 100% vegetarian multivitamin tablets that provide complete
AdjuTec Pharma AS, a privately held company developing antibiotic resistance breakers, today announces that it has entered into a research collaboration agreement with Venus Remedies Limited (India). Venus Remedies Limited will perform a pre-clinical evaluation of AdjuTec Pharma´s APC-148 platform technology. AdjuTec Pharma has developed novel
In a groundbreaking scientific development, researchers have successfully traced the intricate mechanisms involved in the process of cell replication, offering new insights that could pave the way for more effective cancer treatments. This discovery holds immense potential to address one of the fundamental challenges in
The approval marks Venus Remedies’ strategic entry into complex generics, expanding its injectable portfolio beyond traditional formulations With its debut registration of Sugammadex in Philippines, Venus Remedies strengthens its foothold in the ASEAN market Venus Remedies Limited (NSE: VENUSREM, BSE: 526953), a leading Indian manufacturer
MET-X, a novel metallo-beta-lactamase (MBL) inhibitor, has shown best-in-class performance in preclinical studies and could be game-changing for patients suffering from Gram-negative, MBL-resistant infections Meropenem resistance in India is as high as 62-87%, with up to 50% linked to MBL prevalence, according to ICMR
Rusan Pharma Ltd., is a global leader in pharmaceutical innovation, proudly announces that its Chairman, Dr. Navin Saxena, has been honoured with two of Russia’s most distinguished accolades, ‘The Order of Friendship’ by the Russian Federation & the ‘Memorial Medal’ from Moscow’s People’s Friendship University. These honours recognise
